<p>Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 獲取免費報告）董事 Laura Linynsky 於 11 月 6 日星期四出售了 10,000 股公司的股票。該股票的平均售價為 21.65 美元，總價值為 216,500.00 美元。出售後，該董事在公司持有 32,232 股，估值約為 697,822.80 美元。此次交易使其持股減少了 23.68%。該交易已在向美國證券交易委員會（SEC）提交的文件中披露，相關文件可通過 SEC 網站訪問。</p>
<h2>Pediatrix Medical Group 股價上漲 3.0%</h2>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p>MD 的股票在週一的午盤交易中上漲了 0.66 美元，達到了 22.59 美元。該股票的交易量為 1,259,182 股，而其平均交易量為 777,751 股。該公司 50 日簡單移動平均線為 17.29 美元，200 日簡單移動平均線為 15.16 美元。該公司的市值為 19.4 億美元，市盈率為 17.51，貝塔值為 1.20。公司當前比率為 1.80，速動比率為 1.80，債務與股本比率為 0.70。Pediatrix Medical Group, Inc.的 52 周最低價為 11.84 美元，52 周最高價為 22.60 美元。</p>
<p>Pediatrix Medical Group（紐約證券交易所代碼：MD - 獲取免費報告）最近於 11 月 3 日星期一發布了季度財報。公司報告本季度每股收益為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。Pediatrix Medical Group 的淨利潤率為 5.66%，股本回報率為 18.94%。該公司本季度的收入為 4.9288 億美元，而市場共識預期為 4.7645 億美元。去年同期，該公司每股收益為 0.44 美元。該公司的季度收入同比下降了 3.6%。分析師預計 Pediatrix Medical Group, Inc.今年的每股收益將達到 1.38 美元。</p>
<h2>分析師評級變動</h2>
<ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
<p>多家券商最近對 MD 發表了看法。Leerink Partners 將 Pediatrix Medical Group 的目標價從 14.50 美元上調至 17.00 美元，並在 9 月 5 日的報告中給予該公司 “市場表現” 評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Pediatrix Medical Group 股票的 “持有（c）” 評級。Truist Financial 在週一的研究報告中將 Pediatrix Medical Group 的目標價從 17.00 美元上調至 24.00 美元，並給予該公司 “持有” 評級。UBS Group 在 11 月 5 日的研究報告中將 Pediatrix Medical Group 的目標價從 16.50 美元上調至 23.00 美元，並給予該股票 “中性” 評級。最後，Wall Street Zen 在 10 月 4 日的報告中將 Pediatrix Medical Group 的股票評級從 “買入” 上調至 “強力買入”。一位分析師對該股票給予了買入評級，六位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 19.80 美元。</p>
<p><strong>查看我們對 MD 的最新分析</strong></p>
<h2>機構投資者對 Pediatrix Medical Group 的看法</h2>
<ul>
<li>5 只未來自動化的機器人股票值得購買</li>
</ul>
<p>幾家大型投資者最近對 MD 的持倉進行了調整。Marshall &amp; Sullivan Inc. WA 在第二季度購買了 Pediatrix Medical Group 的新頭寸，價值約為 41,000 美元。加拿大養老計劃投資委員會在第二季度收購了 Pediatrix Medical Group 的股份，價值 83,000 美元。AlphaQuest LLC 在第一季度將其在 Pediatrix Medical Group 的持股增加了 16.0%。AlphaQuest LLC 現在持有 5,877 股該公司的股票，價值 85,000 美元，此前在上個季度又購買了 811 股。Quantbot Technologies LP 在第二季度收購了 Pediatrix Medical Group 的新股份，價值 99,000 美元。最後，Smartleaf Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的股份增加了 10.6%。Smartleaf Asset Management LLC 現在持有 6,250 股該公司的股票，價值 101,000 美元，此前在上個季度又購買了 601 股。機構投資者持有該公司 97.71% 的股票。</p>
<h2>Pediatrix Medical Group 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Pediatrix Medical Group, Inc.及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專業護理服務。它提供新生兒護理服務，包括通過新生兒醫生專業人員、新生兒護士執業者和其他兒科臨牀醫生為早產或有併發症的嬰兒提供臨牀護理。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Pediatrix Medical Group</li>
<li>醫療保健股票解析：為什麼你可能想要投資</li>
<li>股價下跌，目標價上升：3 只在上漲超過 10% 後被升級的股票</li>
<li>股息捕捉策略：你需要知道的事項</li>
<li>核能股票正在崩潰——投資者應該恐慌嗎？</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>Monday.com 因瘋狂拋售而開啓了世代機會</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
<p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Pediatrix Medical Group 並不在名單上。</p>
<p>儘管 Pediatrix Medical Group 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

<p>Pediatrix Medical Group 的董事 Laura Linynsky 出售了 10,000 股，平均價格為 21.65 美元，總計 216,500 美元，代表其持股減少了 23.68%。出售後，她持有 32,232 股，價值約為 697,822.80 美元。該交易已向美國證券交易委員會（SEC）披露。該股票最近上漲 3.0%，至 22.59 美元，市值為 19.4 億美元，市盈率為 17.51。分析師的評級不一，平均目標價格為 19.80 美元，普遍評級為 “持有”</p>

<p>Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) Director Laura Linynsky sold 10,000 shares of the business's stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $21.65, for a total value of $216,500.00. Following the sale, the director owned 32,232 shares in the company, valued at approximately $697,822.80. The trade was a 23.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 獲取免費報告）董事 Laura Linynsky 於 11 月 6 日星期四出售了 10,000 股公司的股票。該股票的平均售價為 21.65 美元，總價值為 216,500.00 美元。出售後，該董事在公司持有 32,232 股，估值約為 697,822.80 美元。此次交易使其持股減少了 23.68%。該交易已在向美國證券交易委員會（SEC）提交的文件中披露，相關文件可通過 SEC 網站訪問。</p>
</div><h2>Pediatrix Medical Group Trading Up 3.0%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股價上漲 3.0%</h2>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p>Shares of MD traded up $0.66 during midday trading on Monday, hitting $22.59. The stock had a trading volume of 1,259,182 shares, compared to its average volume of 777,751. The business has a 50-day simple moving average of $17.29 and a two-hundred day simple moving average of $15.16. The firm has a market cap of $1.94 billion, a P/E ratio of 17.51 and a beta of 1.20. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $22.60.</p>
<div class="lb-trans"><p>MD 的股票在週一的午盤交易中上漲了 0.66 美元，達到了 22.59 美元。該股票的交易量為 1,259,182 股，而其平均交易量為 777,751 股。該公司 50 日簡單移動平均線為 17.29 美元，200 日簡單移動平均線為 15.16 美元。該公司的市值為 19.4 億美元，市盈率為 17.51，貝塔值為 1.20。公司當前比率為 1.80，速動比率為 1.80，債務與股本比率為 0.70。Pediatrix Medical Group, Inc.的 52 周最低價為 11.84 美元，52 周最高價為 22.60 美元。</p>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.46 by $0.21. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $492.88 million during the quarter, compared to the consensus estimate of $476.45 million. During the same quarter in the prior year, the firm earned $0.44 EPS. The firm's quarterly revenue was down 3.6% on a year-over-year basis. As a group, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（紐約證券交易所代碼：MD - 獲取免費報告）最近於 11 月 3 日星期一發布了季度財報。公司報告本季度每股收益為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。Pediatrix Medical Group 的淨利潤率為 5.66%，股本回報率為 18.94%。該公司本季度的收入為 4.9288 億美元，而市場共識預期為 4.7645 億美元。去年同期，該公司每股收益為 0.44 美元。該公司的季度收入同比下降了 3.6%。分析師預計 Pediatrix Medical Group, Inc.今年的每股收益將達到 1.38 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
</div><p>A number of brokerages have recently weighed in on MD. Leerink Partners lifted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a &#34;market perform&#34; rating in a report on Friday, September 5th. Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. Truist Financial lifted their target price on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a &#34;hold&#34; rating in a research note on Monday. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen upgraded shares of Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, October 4th. One analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Hold&#34; and an average target price of $19.80.</p>
<div class="lb-trans"><p>多家券商最近對 MD 發表了看法。Leerink Partners 將 Pediatrix Medical Group 的目標價從 14.50 美元上調至 17.00 美元，並在 9 月 5 日的報告中給予該公司 “市場表現” 評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Pediatrix Medical Group 股票的 “持有（c）” 評級。Truist Financial 在週一的研究報告中將 Pediatrix Medical Group 的目標價從 17.00 美元上調至 24.00 美元，並給予該公司 “持有” 評級。UBS Group 在 11 月 5 日的研究報告中將 Pediatrix Medical Group 的目標價從 16.50 美元上調至 23.00 美元，並給予該股票 “中性” 評級。最後，Wall Street Zen 在 10 月 4 日的報告中將 Pediatrix Medical Group 的股票評級從 “買入” 上調至 “強力買入”。一位分析師對該股票給予了買入評級，六位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 19.80 美元。</p>
</div><p><strong>View Our Latest Analysis on MD</strong></p>
<div class="lb-trans"><p><strong>查看我們對 MD 的最新分析</strong></p>
</div><h2>Institutional Investors Weigh In On Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>機構投資者對 Pediatrix Medical Group 的看法</h2>
</div><ul>
<li>5 Robotics Stocks to Buy for the Future of Automation</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只未來自動化的機器人股票值得購買</li>
</ul>
</div><p>Several large investors have recently made changes to their positions in MD. Marshall &amp; Sullivan Inc. WA bought a new position in Pediatrix Medical Group during the second quarter valued at approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter worth $83,000. AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at $99,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Pediatrix Medical Group by 10.6% in the 3rd quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company's stock valued at $101,000 after purchasing an additional 601 shares during the last quarter. Institutional investors own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>幾家大型投資者最近對 MD 的持倉進行了調整。Marshall &amp; Sullivan Inc. WA 在第二季度購買了 Pediatrix Medical Group 的新頭寸，價值約為 41,000 美元。加拿大養老計劃投資委員會在第二季度收購了 Pediatrix Medical Group 的股份，價值 83,000 美元。AlphaQuest LLC 在第一季度將其在 Pediatrix Medical Group 的持股增加了 16.0%。AlphaQuest LLC 現在持有 5,877 股該公司的股票，價值 85,000 美元，此前在上個季度又購買了 811 股。Quantbot Technologies LP 在第二季度收購了 Pediatrix Medical Group 的新股份，價值 99,000 美元。最後，Smartleaf Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的股份增加了 10.6%。Smartleaf Asset Management LLC 現在持有 6,250 股該公司的股票，價值 101,000 美元，此前在上個季度又購買了 601 股。機構投資者持有該公司 97.71% 的股票。</p>
</div><h2>Pediatrix Medical Group Company Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專業護理服務。它提供新生兒護理服務，包括通過新生兒醫生專業人員、新生兒護士執業者和其他兒科臨牀醫生為早產或有併發症的嬰兒提供臨牀護理。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops</li>
<li>Dividend Capture Strategy: What You Need to Know</li>
<li>Nuclear Stocks Are Melting Down—Should Investors Panic?</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>Monday.com Opens Generational Opportunity With Manic Sell-Off</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Pediatrix Medical Group</li>
<li>醫療保健股票解析：為什麼你可能想要投資</li>
<li>股價下跌，目標價上升：3 只在上漲超過 10% 後被升級的股票</li>
<li>股息捕捉策略：你需要知道的事項</li>
<li>核能股票正在崩潰——投資者應該恐慌嗎？</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>Monday.com 因瘋狂拋售而開啓了世代機會</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Pediatrix Medical Group 並不在名單上。</p>
</div><p>While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Pediatrix Medical Group 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Pediatrix Medical Group（NYSE 代碼：MD）的董事 Laura Linynsky 出售了 10,000 股股票